Noticias de PFE_US

Mercado

Noticias del mercado

Últimas noticias sobre PFE_US — 665 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: PFE_US ✕ 665 resultados
19/09/2026 PFE_US — AD HOC NEWS
Pfizer Inc. stock holds near USD 27 as investors weigh dividend and growth outlook

Pfizer Inc. stock traded around USD 27.48 on September 18, 2026, offering a dividend yield of over 6

19/09/2026 PFE_US — Yahoo Finance
Pfizer to Share Revenue With HHS in Deal on Overseas Drug Prices

The US Department of Health and Human Services will get a portion of the increased revenue if Pfizer Inc. is able to charge higher drug prices abroad, according to newly released documents.

18/09/2026 PFE_US — AD HOC NEWS
Pfizer stock holds near USD 27.64 on 6 percent yield

Las acciones de Pfizer cotizaban a 27,64 dólares el 17 de septiembre de 2026, con una capitalización de mercado de 157,51 mil millones de dólares. Mar

17/09/2026 PFE_US — grafa.com
Pfizer BioNTech XFG vaccine receives Health Canada authorization

Health Canada authorized Pfizer and BioNTech’s Omicron XFG-adapted COVID-19 vaccine, with availability expected through Canadian distribution...

17/09/2026 PFE_US — DVM 360
FDA works with Pfizer on injectable opioids for veterinary use

La agencia colabora con una compañía farmacéutica humana para mantener hidromorfona, morfina disponible para el dolor quirúrgico y traumático en animales durante la escasez de suministro.

17/09/2026 PFE_US — PR Newswire Canada
Health Canada Authorizes Pfizer and BioNTech's Omicron XFG-Adapted COVID-19 Vaccine

/CNW/ -- Pfizer Canada ULC and BioNTech SE today announced that Health Canada has authorized the XFG variant-adapted COMIRNATY® for active immunization of...

16/09/2026 PFE_US — OpenSecrets
Pfizer Inc Agencies, 2020
16/09/2026 PFE_US — AD HOC NEWS
Pfizer stock heads into the open after a 0.3% dip

At the close on September 15, 2026, Pfizer stock finished at USD 27.55 on the NYSE, down 0.3%, while

15/09/2026 PFE_US — Yahoo Finance
Pfizer (PFE), Valneva (VALN) Lyme Vaccine Moves to EMA Review Despite Phase 3 Caveat

Pfizer Inc. (NYSE:PFE) y Valneva SE (NASDAQ:VALN) informaron el 14 de agosto que la Agencia Europea de Medicamentos ha validado la solicitud de autorización de comercialización para PF-07307405, la vacuna candidata experimental de las empresas contra la enfermedad de Lyme, y ahora comenzará la revisión oficial. Para una vacuna candidata propuesta por primera vez en un acuerdo de colaboración de 2020 entre Pfizer Inc. (NYSE:PFE) y French […]

15/09/2026 PFE_US — Yahoo Finance
Is Trending Stock Pfizer Inc. (PFE) a Buy Now?

Recently, Zacks.com users have been paying close attention to Pfizer (PFE). This makes it worthwhile to examine what the stock has in store.

14/09/2026 PFE_US — ad-hoc-news.de
Pfizer stock heads into the open after a modest gain

At the close on September 14, 2026, Pfizer stock added a modest percent gain on the NYSE while the S

Página 26 de 34